CME Group challenges CFTC approval of crypto perpetual futures

Traders Union
All News
Financial News
CME vs CFTC crypto futures

Highlights

CME Group sues the CFTC over approval of Kalshi's bitcoin-linked perpetual futures, arguing the decision violates Congress's definition of swaps.
CME alleges Kalshi has self-certified more than a dozen crypto perpetuals under the ruling, with trading volumes already exceeding $1 billion.
The lawsuit could trigger tighter regulatory oversight for crypto perpetual contracts and impact the speed at which U.S. exchanges roll out such products.

Legal challenge targets crypto derivatives approval

As reported by Financial Times, CME Group files suit against the CFTC after the regulator approves Kalshi to list perpetual contracts tied to bitcoin as futures. The exchange argues that the decision, made by Chair Michael Selig acting as the sole confirmed commissioner, fails to address whether products with those structural features fall under Congress's definition of swaps.

The lawsuit says the CFTC order closely mirrors Kalshi's own reasoning and does not explain a break from the agency's earlier and consistent view that perpetuals are swaps. CME also challenges an accompanying policy statement that it says allows futures exchanges to self-certify similar cryptocurrency perpetual contracts without prior CFTC approval.

According to the complaint, Kalshi has already self-certified more than a dozen additional crypto perpetuals under the order and brought them to market. CME says that trading in those products already exceeds $1 billion, raising the commercial stakes of the dispute as well as the regulatory ones.

Regulatory and market implications for U.S. exchanges

The lawsuit highlights a broader fight over the boundary between futures and swaps regulation in U.S. derivatives markets. If CME's argument prevails, the ruling could force tighter oversight of crypto perpetual contracts and limit how quickly exchanges can launch similar instruments.

The dispute also reflects competitive pressure within exchange markets, where new crypto-linked products can generate significant volumes. CME has signaled for days that it opposes the approval, and chief executive Terry Duffy tells CNBC he is ready for a "good battle" over the issue.

The case places Michael Selig and the CFTC's handling of crypto derivatives under sharper scrutiny at a time when regulators are weighing how far existing market rules extend to digital-asset products. It also underscores how procedural decisions at the commission can quickly reshape product pipelines and trading activity across the sector.

Our earlier article on Cboe’s entry into prediction markets explained how the exchange launched binary-style contracts tied to the Mini-S&P 500 Index, targeting rising retail demand for short-term, outcome-based trading. It also highlighted how bringing these products onto regulated exchange infrastructure could widen broker access and intensify debate over where prediction-style contracts fit within the U.S. derivatives rulebook.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.